Literature DB >> 29384597

Uniportal video-assisted thoracoscopic surgery for anatomical fissureless anterior segment resection (S3) of the right upper lobe followed by lymph node dissection.

Davor Stamenovic1, Antje Messerschmidt2.   

Abstract

Uniportal video-assisted thoracoscopic (UVATS) resections seem to offer real benefits over conventional surgery in terms of postoperative pain and better cosmetic results.  The procedure described in this tutorial, an anterior segment resection of the right upper lobe, is rarely performed, and fissureless resection of this segment by means of UVATS has, at time of writing, never been described in the literature.  Our patient was a 79-year-old female, admitted to our clinic for treatment of a solitary metachronous metastatic tumor of a colon carcinoma, located in the anterior segment of the right upper lobe. A fissureless anatomical anterior segment resection of the right upper lobe was conducted, followed by the radical lymph node dissection.  The postoperative course was event free and the patient was discharged on the 4th postoperative day. Fissureless VATS operations have an advantage compared to conventional operations in terms of reduced risk of prolonged air leak. Moreover, these operations take no longer to perform than conventional surgery and have no notable disadvantages, apart from the potential for using more staples.
© The Author 2016. Published by MMCTS on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29384597     DOI: 10.1510/mmcts.2018.001

Source DB:  PubMed          Journal:  Multimed Man Cardiothorac Surg        ISSN: 1813-9175


  1 in total

1.  Research on the application of uniportal video-assisted thoracoscopic segmental resection of the lung in elderly patients with non-small cell lung cancer aged over 65 years.

Authors:  Hongya Xie; Jinxing Tang; Donglin Zhu; Guangda Yuan; Tengteng Wei; Xiaoqiang Liu; Yong Yang
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2021-06-04       Impact factor: 1.195

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.